Ngā hua rapu :: APM

1

Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia mā Gaetano Maria De Ferrari, Veronica Dusi, Carla Spazzolini, J. Martijn Bos, Dominic J. Abrams, Charles I. Berul, Lia Crotti, Andrew M. Davis, Michael Eldar, М. С. Харлап, Asaad Khoury, Andrew D. Krahn, Antoine Leenhardt, Christopher R. Moir, Attilio Odero, Louise R.A. Olde Nordkamp, Thomas Paul, Ferran Rosés‐Noguer, M. А. Shkolnikova, Jan Till, Arthur A.M. Wilde, Michael J. Ackerman, Peter J. Schwartz

I whakaputaina 2015

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

The use of implantable cardioverter defibrillators in pediatric patients mā Valquíria Pelisser Campagnucci, A Silva, Wilson Lopes Pereira, Alexey Pomares Peroni, Eduardo Gregório Chamlian, Sylvio M. A. Gandra, A Scatolini, Uelra Rita Lourenço, FAC Silva, Luiz Antônio Rivetti

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Catecholaminergic Polymorphic Ventricular Tachycardia mā Krystien V.V. Lieve, Christian van der Werf, Arthur A.M. Wilde

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
4

Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with β1-selective β-blockers in patients with catecholaminergic poly... mā Ida S. Leren, Jørg Saberniak, Eman Majid, Trine F. Håland, Thor Edvardsen, Kristina H. Haugaa

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Antiarrhythmic Effects of Dantrolene in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia and Replication of the Responses Using iPSC Models mā Kirsi Penttinen, Heikki Swan, Sari Vanninen, Jere Paavola, Annukka M. Lahtinen, Kimmo Kontula, Katriina Aalto‐Setälä

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Inherited arrhythmias: The cardiac channelopathies mā ShashankP Behere, StevenN Weindling

I whakaputaina 2015

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
7

Functional abnormalities in iPSC‐derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations mā Atara Novak, Lili Barad, Avraham Lorber, Mihaela Gherghiceanu, Irina Reiter, Binyamin Eisen, Liron Eldor, Joseph Itskovitz‐Eldor, Michael Eldar, Michael Arad, Ofer Binah

I whakaputaina 2015

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia mā Meiso Hayashi, Isabelle Denjoy, Fabrice Extramiana, Alice Maltret, Nathalie Roux Buisson, Jean‐Marc Lupoglazoff, Didier Klug, Miyuki Hayashi, Seiji Takatsuki, E Villain, J Kamblock, A. Messali, Pascale Guicheney, Joël Lunardi, Antoine Leenhardt

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Dantrolene, a Therapeutic Agent for Malignant Hyperthermia, Markedly Improves the Function of Failing Cardiomyocytes by Stabilizing Interdomain Interactions Within the Ryanodine Re... mā Shigeki Kobayashi, Masafumi Yano, Takeshi Suetomi, Makoto Ono, Hiroki Tateishi, Mamoru Mochizuki, Xiaojuan Xu, Hitoshi Uchinoumi, Shinichi Okuda, Takeshi Yamamoto, Noritaka Koseki, Hiroyuki Kyushiki, Noriaki Ikemoto, Masunori Matsuzaki

I whakaputaina 2009

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Calmodulin kinase II–mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice mā Mihail G. Chelu, Satyam Sarma, Subeena Sood, Sufen Wang, Ralph J. van Oort, Darlene G. Skapura, Na Li, Marco Santonastasi, Frank U. Müller, Wilhelm Schmitz, Ulrich Schotten, Mark E. Anderson, Miguel Valderrábano, Dobromir Dobrev, Xander H.T. Wehrens

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Sudden Death in Familial Polymorphic Ventricular Tachycardia Associated With Calcium Release Channel (Ryanodine Receptor) Leak mā Stephan E. Lehnart, Xander H.T. Wehrens, Päivi J. Laitinen, Steven Reiken, Shi-Xiang Deng, Zhenzhuang Cheng, Donald W. Landry, Kimmo Kontula, Heikki Swan, Andrew R. Marks

I whakaputaina 2004

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Reveals Early and Delayed Afterdepolarizations mā Kirsi Kujala, Jere Paavola, Anna Lahti, Kim Larsson, Mari Pekkanen-Mattila, Matti Viitasalo, Annukka M. Lahtinen, Lauri Toivonen, Kimmo Kontula, Heikki Swan, Mika Laine, Olli Silvennoinen, Katriina Aalto‐Setälä

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Genetic Testing for Potentially Lethal, Highly Treatable Inherited Cardiomyopathies/Channelopathies in Clinical Practice mā David J. Tester, Michael J. Ackerman

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
14

Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy mā Prince J. Kannankeril, Brett M. Mitchell, Sanjeewa A. Goonasekera, Mihail G. Chelu, Wei Zhang, Subeena Sood, Debra L. Kearney, Cristina I. Danila, Mariella De Biasi, Xander H.T. Wehrens, Robia G. Pautler, Dan M. Roden, George E. Taffet, Robert T. Dirksen, Mark E. Anderson, Susan L. Hamilton

I whakaputaina 2006

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca <sup>2+</sup> release (SOICR) mā Dawei Jiang, Bailong Xiao, Dongmei Yang, Ruiwu Wang, Philip Choi, Lin Zhang, Heping Cheng, S. R. Wayne Chen

I whakaputaina 2004

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Successful Catheter Ablation of Bidirectional Ventricular Premature Contractions Triggering Ventricular Fibrillation in Catecholaminergic Polymorphic Ventricular Tachycardia With <... mā Takashi Kaneshiro, Yoshihisa Naruse, Akihiko Nogami, Hiroshi Tada, Kentaro Yoshida, Yukio Sekiguchi, Nobuyuki Murakoshi, Yoshiaki Kato, Hitoshi Horigome, Mihoko Kawamura, Minoru Horie, Kazutaka Aonuma

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

A mechanism for sudden infant death syndrome (SIDS): Stress-induced leak via ryanodine receptors mā David J. Tester, Miroslav Důra, Elisa Carturan, Steven Reiken, Anetta Wronska, Andrew R. Marks, Michael J. Ackerman

I whakaputaina 2007

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Autosomal Recessive Catecholamine- or Exercise-Induced Polymorphic Ventricular Tachycardia mā Hadas Lahat, Michael Eldar, Etgar Levy‐Nissenbaum, Tangiz Bahan, Eitan Friedman, Asad Khoury, Avraham Lorber, Daniel L. Kastner, Boleslaw Goldman, Elon Pras

I whakaputaina 2001

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

Ryanodine receptor channelopathies mā Matthew J. Betzenhauser, Andrew R. Marks

I whakaputaina 2010

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
20

Drug-Induced Torsade de Pointes. From Molecular Biology to Bedside. mā Juan Tamargo

I whakaputaina 2000

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i: